PHAXIAM Therapeutics S.A.
PHAXIAM Therapeutics S.A. (PHXM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PHXM · as of Jun 9, 2026
Key Statistics
Explore PHAXIAM Therapeutics S.A. Data
phxm stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
phxm competitorsPHXM
ATON
CSCI
DOMH
ELEV
KAStock Performance
Full HistoryAbout PHAXIAM Therapeutics S.A.
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes ery…
what is phaxiam therapeutics s.a. · phxm stock overview · phaxiam therapeutics s.a. company profile · who is phaxiam therapeutics s.a. ceo · phxm NASDAQ · phaxiam therapeutics s.a. headquarters · phaxiam therapeutics s.a. business segments
About Stock Overview & Key Data
PHAXIAM Therapeutics S.A. (PHXM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 26, 2017. As of the latest trading session, PHXM stock price is $3.10, with a market capitalization of $19.9M. The stock has returned -62.92% over the past 12 months and -35.42% year-to-date.
In fiscal year 2023, PHAXIAM Therapeutics S.A. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PHAXIAM Therapeutics S.A. (PHXM) stock price is $3.10. The stock is traded on NASDAQ under the ticker symbol PHXM. The 52-week range is $2.50 – $13.00.